The senescent microenvironment promotes the emergence of heterogeneous cancer stem-like cells

Carcinogenesis

Volumn 36, Issue 10, 2015, Pages 1180-1192

  Castro Vega, Luis Jaime ^a,b   Jouravleva, Karina ^a,b   Ortiz Montero, Paola ^c   Liu, Win Yan ^a,b   Galeano, Jorge Luis ^c   Romero, Martha ^d   Popova , Tatiana ^e   Bacchetti, Silvia ^f   Vernot, Jean Paul ^c   Londoño Vallejo, Arturo ^a,b  

^a INSTITUT CURIE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN SANTA FE DE BOGOTÁ   (Colombia)

^e INSTITUT CURIE   (France)

^f REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE; STROMA CELL; TELOMERE; TUMOR MICROENVIRONMENT; AGING; BIOSYNTHESIS; CELL AGING; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOMAL INSTABILITY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

MICRORNA;

AGING; CELL AGING; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; TELOMERE; TUMOR MICROENVIRONMENT;

EID: 84943781615     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv101     Document Type: Article

References (61)

1. Armitage, P. et al. (1954) The age distribution of cancer and a multistage theory of carcinogenesis. Br. J. Cancer, 8, 1-12.
2. Campisi, J. (2013) Aging, cellular senescence, and cancer. Annu. Rev. Physiol., 75, 685-705.
3. Harley, C.B. et al. (1990) Telomeres shorten during ageing of human fibroblasts. Nature, 345, 458-460.
4. Frenck, R.W. et al. (1998) The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA, 95, 5607-5610.
5. DePinho, R.A. (2000) The age of cancer. Nature, 408, 248-254.
6. Willeit, P. et al. (2010) Telomere length and risk of incident cancer and cancer mortality. JAMA, 304, 69-75.
7. Chin, K. et al. (2004) In situ analyses of genome instability in breast cancer. Nat. Genet., 36, 984-988.
8. Meeker, A.K. et al. (2002) Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res., 62, 6405-6409.
9. van Heek, N.T. et al. (2002) Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am. J. Pathol., 161, 1541-1547.
10. Ding, Z. et al. (2012) Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell, 148, 896-907.
11. Castro-Vega, L.J. et al. (2013) Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas. Carcinogenesis, 34, 1173-1180.
12. Velarde, M.C. et al. (2013) Senescent cells and their secretory phenotype as targets for cancer therapy. Interdiscip. Top Gerontol., 38, 17-27.
13. Coppe, J.P. et al. (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol., 5, 99-118.
14. Krtolica, A. et al. (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. USA, 98, 12072-12077.
15. Parrinello, S. et al. (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci., 118, 485-496.
16. Coppe, J.P. et al. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol., 6, 2853-2868.
17. Olumi, A.F. et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res., 59, 5002-5011.
18. Bavik, C. et al. (2006) The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res., 66, 794-802.
19. Cahu, J. et al. (2012) Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells. Cell Death Dis., 3, e446.
20. Stewart, N. et al. (1991) Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology, 180, 49-57.
21. der-Sarkissian, H. et al. (2004) The shortest telomeres drive karyotype evolution in transformed cells. Oncogene, 23, 1221-1228.
22. Hahn, W.C. et al. (1999) Creation of human tumour cells with defined genetic elements. Nature, 400, 464-468.
23. Schmittgen, T.D. et al. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc., 3, 1101-1108.
24. Farmer, S.R. (2006) Transcriptional control of adipocyte formation. Cell Metab., 4, 263-273.
25. Rosen, E.D. (2005) The transcriptional basis of adipocyte development. Prostaglandins Leukot. Essent. Fatty Acids, 73, 31-34.
26. Phillips, J.E. et al. (2006) Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J. Cell Sci., 119, 581-591.
27. Chen, W.H. et al. (2009) In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. Arthritis Rheum., 60, 450-459.
28. Popova, T. et al. (2009) Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol., 10, R128.
29. Xu, N. et al. (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell, 137, 647-658.
30. Huang, S. et al. (2012) miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells. Oncol Rep., 28, 1831-1837.
31. Tlsty, T.D. et al. (2006) Tumor stroma and regulation of cancer development. Annu. Rev. Pathol., 1, 119-150.
32. Ben-Porath, I. et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet., 40, 499-507.
33. Chaffer, C.L. et al. (2011) A perspective on cancer cell metastasis. Science, 331, 1559-1564.
34. Gupta, P.B. et al. (2009) Cancer stem cells: mirage or reality? Nat. Med., 15, 1010-1012.
35. Tsuji, T. et al. (2008) Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res., 68, 10377-10386.
36. Celia-Terrassa, T. et al. (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J. Clin. Invest., 122, 1849-1868.
37. Friedmann-Morvinski, D. et al. (2014) Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep., 15, 244-253.
38. Mani, S.A. et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-715.
39. Polyak, K. et al. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer, 9, 265-273.
40. Li, R. et al. (2010) A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell, 7, 51-63.
41. Samavarchi-Tehrani, P. et al. (2010) Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell, 7, 64-77.
42. Wang, G. et al. (2013) Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc. Natl. Acad. Sci. USA, 110, 2858-2863.
43. Pucci, F. et al. (2013) Short telomeres in ESCs lead to unstable differentiation. Cell Stem Cell, 12, 479-486.
44. Hirashima, K. et al. (2013) Telomere length influences cancer cell differentiation in vivo. Mol. Cell Biol., 33, 2988-2995.
45. Larne, O. et al. (2013) miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int. J. Cancer, 132, 2867-2875.
46. Campayo, M. et al. (2013) Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. Eur. Respir. J., 41, 1172-1178.
47. Karakatsanis, A. et al. (2013) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol. Carcinog., 52, 297-303.
48. Yu, M. et al. (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science, 339, 580-584.
49. Husemann, Y. et al. (2008) Systemic spread is an early step in breast cancer. Cancer Cell, 13, 58-68.
50. Rhim, A.D. et al. (2012) EMT and dissemination precede pancreatic tumor formation. Cell, 148, 349-361.
51. Klein, C.A. (2009) Parallel progression of primary tumours and metastases. Nat. Rev. Cancer, 9, 302-312.
52. Hu, J. et al. (2014) MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells. Tumour Biol., 35, 8953-8961.
53. Giancotti, F.G. (2013) Mechanisms governing metastatic dormancy and reactivation. Cell, 155, 750-764.
54. Scheel, C. et al. (2007) Adaptation versus selection: the origins of metastatic behavior. Cancer Res., 67, 11476-11479.55. Chaffer, C.L. et al. (2015) How does multistep tumorigenesis really proceed? Cancer Discov., 5, 22-24.
55. Meeker, A.K. et al. (2004) Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res., 10, 3317-3326.
56. Heaphy, C.M. et al. (2013) Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discov., 3, 1130-1141.
57. Bernards, R. et al. (2002) A progression puzzle. Nature, 418, 823.
58. Jones, S. et al. (2008) Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl. Acad. Sci. USA, 105, 4283-4288.
59. Kreso, A. et al. (2014) Evolution of the cancer stem cell model. Cell Stem Cell, 14, 275-291.
60. Burrell, R.A. et al. (2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature, 501, 338-345.
61. Burrell, R.A. et al. (2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature, 501, 338-345.